MGM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Based on the data provided, MGM Resorts International does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. While the company has shown strong financial growth in the latest quarter and hedge funds are increasing their positions, the technical indicators are neutral, options data reflects bearish sentiment, and analysts' ratings are mixed with limited upside potential. Additionally, the stock trend analysis predicts a decline in the short to medium term, making it prudent to hold off on buying at this time.
The MACD is positive but contracting, indicating a weakening bullish momentum. RSI is neutral at 35.737, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot point of 35.856, with key support at 33.289 and resistance at 38.423. Overall, the technical indicators suggest a neutral to slightly bearish trend.
Hedge funds are significantly increasing their positions, with a 161.90% rise in buying activity over the last quarter.
Strong Q4 financial performance, with revenue up 5.95% YoY, net income up 93.66% YoY, and EPS up 107.69% YoY.
Analysts from Texas Capital and Stifel have issued high price targets of $56 and $50, respectively, citing potential growth in Las Vegas, Macau, and BetMGM value.
Mixed analyst ratings, with Morgan Stanley maintaining an Underweight rating and citing weaker fundamentals in MGM's core Las Vegas segment.
Stock trend analysis predicts a decline of -1.21% in the next day, -4.04% in the next week, and -6.83% in the next month.
Options data reflects bearish sentiment, with a higher put-call ratio and declining implied volatility rank.
In Q4 2025, MGM Resorts reported strong financial growth: Revenue increased by 5.95% YoY to $4.61 billion, net income surged by 93.66% YoY to $299.23 million, and EPS rose by 107.69% YoY to $1.08. However, gross margin declined by 3.28% YoY to 37.98%.
Analyst ratings are mixed. While some analysts, like Stifel and Texas Capital, have issued high price targets ($50 and $56) and Buy ratings, others, like Morgan Stanley and Barclays, have expressed concerns about weaker fundamentals and issued lower price targets ($34 and $37). The consensus view suggests limited upside in the near term.
